M, K., S, S., N, P., A, K., V, P., L, M., . . . TS, P. (2021). Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: Insights from the BALKAN-AF survey. Annals of medicine, 53(1), 17. https://doi.org/10.1080/07853890.2020.1799241
Chicago Style (17th ed.) CitationM, Kozieł, et al. "Impact of Multimorbidity and Polypharmacy on the Management of Patients with Atrial Fibrillation: Insights from the BALKAN-AF Survey." Annals of Medicine 53, no. 1 (2021): 17. https://doi.org/10.1080/07853890.2020.1799241.
MLA (9th ed.) CitationM, Kozieł, et al. "Impact of Multimorbidity and Polypharmacy on the Management of Patients with Atrial Fibrillation: Insights from the BALKAN-AF Survey." Annals of Medicine, vol. 53, no. 1, 2021, p. 17, https://doi.org/10.1080/07853890.2020.1799241.